Endocannabinoids measurement in human saliva as potential biomarker of obesity. - Wikidata - awgldk - TriplyDB

Endocannabinoids measurement in human saliva as potential biomarker of obesity.

Endocannabinoids measurement in human saliva as potential biomarker of obesity.

http://www.wikidata.org/entity/Q34364857

about

Care and feeding of the endocannabinoid system: a systematic review of potential clinical interventions that upregulate the endocannabinoid system.Is fat taste ready for primetime?Cannabis use by individuals with multiple sclerosis: effects on specific immune parameters.New insights on the role of the endocannabinoid system in the regulation of energy balance.Circulating Endocannabinoids and the Polymorphism 385C>A in Fatty Acid Amide Hydrolase (FAAH) Gene May Identify the Obesity Phenotype Related to Cardiometabolic Risk: A Study Conducted in a Brazilian Population of Complex Interethnic Admixture Endocannabinoid signaling in the gut mediates preference for dietary unsaturated fats Fatty Acid modulation of the endocannabinoid system and the effect on food intake and metabolism.Detection of inflammatory biomarkers in saliva and urine: Potential in diagnosis, prevention, and treatment for chronic diseases CB1 cannabinoid receptors couple to focal adhesion kinase to control insulin release.Characterization of endocannabinoid-mediated induction of myeloid-derived suppressor cells involving mast cells and MCP-1.Oleoylethanolamide: a novel potential pharmacological alternative to cannabinoid antagonists for the control of appetite Analytical approaches for the determination of phytocannabinoids and endocannabinoids in human matrices.Biomarkers in the field of obesity and its related comorbidities.The endocannabinoid system and appetite: relevance for food reward.Circulating Endocannabinoids: From Whence Do They Come and Where are They Going?Effect of whey protein supplementation on levels of endocannabinoids and some of metabolic risk factors in obese women on a weight-loss diet: a study protocol for a randomized controlled trial.Peripheral endocannabinoid signaling controls hyperphagia in western diet-induced obesity.Evaluation of plasma-free endocannabinoids and their congeners in abstinent cocaine addicts seeking outpatient treatment: impact of psychiatric co-morbidity.Developing a deeper insight into reproductive biomarkers.

P2860

Q21132308-54C32091-BB56-4645-B611-F60C9B0CA9BC Q22337316-0D20F6AE-6C3E-471C-9EBF-5F74EE894B4D Q34219132-0A86ED14-C7EC-460C-B5AC-600559833287 Q34494301-D421CC0A-AA78-423E-A79E-42A2207E99A6 Q35839405-A87B06C1-0D24-410E-8C8E-703B20BCB01F Q36860344-B35A3D91-B0EF-4920-9B80-D88052460C42 Q36916109-BB2534F4-3DDF-4F71-B613-A061420C507D Q37107248-BACC97E8-B6C6-4654-BDE4-983C03E06A65 Q37289307-4E91F07B-9B31-47D3-9FC3-892007A31AA5 Q37644978-F23C471E-529F-4EDC-BE09-A60EBAD80FB5 Q37717854-E3C7C527-6F6E-4168-8A73-745D7D7CF221 Q38161854-5BE40803-3EEB-4CEC-AF52-D95367110508 Q38183431-F4502758-CC9D-4A42-A0D7-9EA05FE5F917 Q38220568-C8620615-2C22-48B1-80AA-D73564CFBB28 Q38707482-463D8C44-A829-4153-857E-994ABF6EE24C Q42643743-9878C641-893E-4575-9D54-ED2F86916E84 Q45995526-EDB36F43-9A6B-4885-BC61-AB355A8F8D58 Q46662676-C0B3C37C-758F-4211-AB3E-A30AC6A7639A Q49627412-62B55724-7AB7-4F3F-9520-12D9166F7E16

P2860

Endocannabinoids measurement in human saliva as potential biomarker of obesity.

http://www.wikidata.org/entity/Q34364857

description

2012 nî lūn-bûn

@nan

2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

name

Endocannabinoids measurement in human saliva as potential biomarker of obesity.

@ast

Endocannabinoids measurement in human saliva as potential biomarker of obesity.

@en

Endocannabinoids measurement in human saliva as potential biomarker of obesity.

@nl

type

label

Endocannabinoids measurement in human saliva as potential biomarker of obesity.

@ast

Endocannabinoids measurement in human saliva as potential biomarker of obesity.

@en

Endocannabinoids measurement in human saliva as potential biomarker of obesity.

@nl

prefLabel

Endocannabinoids measurement in human saliva as potential biomarker of obesity.

@ast

Endocannabinoids measurement in human saliva as potential biomarker of obesity.

@en

Endocannabinoids measurement in human saliva as potential biomarker of obesity.

@nl

P1433

Q34364857-A13EC7F0-BF19-4611-BE17-78E4E1ED2929

P1476

Q34364857-558F805A-CEF6-43CF-852D-729BF4156F42

P2093

Q34364857-056C62FD-2219-4ADC-A46C-6DAC8C675BE9

Q34364857-1976F8DE-EE69-4E43-BEC3-14C7FCB07978

Q34364857-737FA3C6-BE4B-49DA-A115-81372EBA0A27

Q34364857-9EC137A0-70B0-493E-BE14-BBC699EECF7F

Q34364857-A80671C5-1CAE-4B85-A870-23EA6F5856A7

Q34364857-BCDF823B-000A-4705-B78E-65C72A8D145B

P2860

Q34364857-056C26EE-0B2B-411D-A2AC-9131613A8A40

Q34364857-0B20BE44-7B16-4F47-9534-0769B9826DBC

Q34364857-0DAE669B-D651-45CA-A895-E5880F4392F1

Q34364857-165DADE3-5076-4002-873D-553FCC1BFAD8

Q34364857-19697080-189B-48AA-A6DF-75DA420186BA

Q34364857-1E658414-4361-4F1A-9175-E553D78D2589

Q34364857-1E73A121-27E2-4500-8DCF-6844CC8ACD04

Q34364857-1F5BA4AE-7F78-45E0-BDE4-BCAFF1029B9C

Q34364857-2D596C9D-B4CB-4FF5-841E-371A1D77D8F5

Q34364857-34CC4297-9C76-4877-90B4-C19839FDF61D

P304

Q34364857-8D682470-260D-49CB-AC62-2A9059660DF2

P31

Q34364857-618C86C1-078A-4529-A999-18EC16D7A145

P356

Q34364857-84585689-1FFA-41E3-81EC-F56B08F0F1EA

P407

Q34364857-174D2228-A7D3-441F-B3A8-B05F4F2070ED

P433

Q34364857-B90E67F1-E00C-4387-9F27-4E6262880E08

P478

Q34364857-F33CE896-17A6-4E1B-8C58-1806088B45C3

P50

Q34364857-4AD93900-D873-444E-AE52-F3243A1A5D00

Q34364857-E174F7AE-BA9B-4F3F-9B49-9FAEBEEFF903

P577

Q34364857-8DF1E25A-BCEC-45C3-A307-5F854404DBA5

P5875

Q34364857-17E76C15-34E3-402B-8E09-E2C53C3D5C3C

P698

Q34364857-E8F42C77-DE5C-47A9-AFD1-2A26AC95FC3B

P921

Q34364857-5E95098C-1477-448D-BC39-43A58463DD17

Q34364857-84AB29C4-611E-44F7-8BF3-AD6CA3F8B94F

Q34364857-8A057A42-CCC2-4C8F-8313-F1BBFFBBF572

P932

Q34364857-812D9E3D-8630-4D22-A569-09038DDA9E0B

P356

JOURNAL.PONE.0042399

P1433

P1476

Endocannabinoids measurement in human saliva as potential biomarker of obesity

@en

P2093

Antoine Tabarin

http://www.w3.org/2001/XMLSchema#string

Blandine Gatta-Cherifi

http://www.w3.org/2001/XMLSchema#string

Isabelle Matias

http://www.w3.org/2001/XMLSchema#string

Pier Vincenzo Piazza

http://www.w3.org/2001/XMLSchema#string

Samantha Clark

http://www.w3.org/2001/XMLSchema#string

Thierry Leste-Lasserre

http://www.w3.org/2001/XMLSchema#string

P2860

Salivary PYY: a putative bypass to satiety

Endocannabinoids selectively enhance sweet taste

Activation of the peripheral endocannabinoid system in human obesity

Molecular characterization of a phospholipase D generating anandamide and its congeners

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

Biomarkers of endocannabinoid system activation in severe obesity

Plasma anandamide and other N-acylethanolamines are correlated with their corresponding free fatty acid levels under both fasting and non-fasting conditions in women

Therapeutic aspects of cannabis and cannabinoids.

Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes.

Regulation of food intake by oleoylethanolamide.

P304

e42399

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0042399

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Giovanni Marsicano

P577

2012-07-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230617002

http://www.w3.org/2001/XMLSchema#string

P698

22860123

http://www.w3.org/2001/XMLSchema#string

P921

endocannabinoids

P932

3409167

http://www.w3.org/2001/XMLSchema#string